These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11967494)

  • 1. Use of topical recombinant human platelet-derived growth factor BB in abdominal wound separation.
    Shackelford DP; Fackler E; Hoffman MK; Atkinson S
    Am J Obstet Gynecol; 2002 Apr; 186(4):701-4. PubMed ID: 11967494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study.
    Wieman TJ; Smiell JM; Su Y
    Diabetes Care; 1998 May; 21(5):822-7. PubMed ID: 9589248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II study to evaluate recombinant platelet-derived growth factor-BB in the treatment of stage 3 and 4 pressure ulcers.
    Mustoe TA; Cutler NR; Allman RM; Goode PS; Deuel TF; Prause JA; Bear M; Serdar CM; Pierce GF
    Arch Surg; 1994 Feb; 129(2):213-9. PubMed ID: 8304833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Becaplermin gel in the treatment of pressure ulcers: a phase II randomized, double-blind, placebo-controlled study.
    Rees RS; Robson MC; Smiell JM; Perry BH
    Wound Repair Regen; 1999; 7(3):141-7. PubMed ID: 10417749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical platelet-derived growth factor in patients enhances wound closure in the absence of wound contraction.
    Ehrlich HP; Freedman BM
    Cytokines Cell Mol Ther; 2002; 7(3):85-90. PubMed ID: 12850807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine A2A receptor agonists promote more rapid wound healing than recombinant human platelet-derived growth factor (Becaplermin gel).
    Victor-Vega C; Desai A; Montesinos MC; Cronstein BN
    Inflammation; 2002 Feb; 26(1):19-24. PubMed ID: 11936752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Original articles: ease of wound closure as an endpoint of treatment efficacy.
    Robson MC; Maggi SP; Smith PD; Wassermann RJ; Mosiello GC; Hill DP; Cooper DM
    Wound Repair Regen; 1999; 7(2):90-6. PubMed ID: 10231510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-derived growth factor BB for the treatment of chronic pressure ulcers.
    Robson MC; Phillips LG; Thomason A; Robson LE; Pierce GF
    Lancet; 1992 Jan; 339(8784):23-5. PubMed ID: 1345953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of becaplermin (rhPDGF-BB) gel. Becaplermin Gel Studies Group.
    Wieman TJ
    Am J Surg; 1998 Aug; 176(2A Suppl):74S-79S. PubMed ID: 9777976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Becaplermin gel (PDGF-BB) as topical wound therapy. Plastic Surgery Educational Foundation DATA Committee.
    Ladin D
    Plast Reconstr Surg; 2000 Mar; 105(3):1230-1. PubMed ID: 10724287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of platelet-derived growth factor BB in accelerating wound healing in aged versus young animals: the impact of tissue hypoxia.
    Wu L; Brucker M; Gruskin E; Roth SI; Mustoe TA
    Plast Reconstr Surg; 1997 Mar; 99(3):815-22; discussion 823-4. PubMed ID: 9047202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical treatment of hypertensive leg ulcers with platelet-derived growth factor-BB: a randomized controlled trial.
    Senet P; Vicaut E; Beneton N; Debure C; Lok C; Chosidow O
    Arch Dermatol; 2011 Aug; 147(8):926-30. PubMed ID: 21482863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies.
    Smiell JM; Wieman TJ; Steed DL; Perry BH; Sampson AR; Schwab BH
    Wound Repair Regen; 1999; 7(5):335-46. PubMed ID: 10564562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of becaplermin gel and Kollagen Medifil particles.
    Tomaselli NL
    J Wound Ostomy Continence Nurs; 2000 Nov; 27(6):319-20. PubMed ID: 11096412
    [No Abstract]   [Full Text] [Related]  

  • 15. Off-label use of becaplermin gel (recombinant platelet-derived growth factor-BB) for treatment of mucosal defects after corticocancellous bone graft: report of 2 cases with review of the literature.
    Calhoun CC; Cardenes O; Ducksworth J; Le AD
    J Oral Maxillofac Surg; 2009 Nov; 67(11):2516-20. PubMed ID: 19837327
    [No Abstract]   [Full Text] [Related]  

  • 16. Human plasma fibronectin potentiates the mitogenic activity of platelet-derived growth factor and complements its wound healing effects.
    Larivière B; Rouleau M; Picard S; Beaulieu AD
    Wound Repair Regen; 2003; 11(1):79-89. PubMed ID: 12581430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of becaplermin in the closure of pharyngocutaneous fistulas.
    Jakubowicz DM; Smith RV
    Head Neck; 2005 May; 27(5):433-8. PubMed ID: 15776464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue repair processes in healing chronic pressure ulcers treated with recombinant platelet-derived growth factor BB.
    Pierce GF; Tarpley JE; Allman RM; Goode PS; Serdar CM; Morris B; Mustoe TA; Vande Berg J
    Am J Pathol; 1994 Dec; 145(6):1399-410. PubMed ID: 7992843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of platelet-derived growth factor as an adjunct to surgery in the management of pressure ulcers.
    Kallianinen LK; Hirshberg J; Marchant B; Rees RS
    Plast Reconstr Surg; 2000 Nov; 106(6):1243-8. PubMed ID: 11083552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open-label clinical evaluation of efficacy.
    Embil JM; Papp K; Sibbald G; Tousignant J; Smiell JM; Wong B; Lau CY
    Wound Repair Regen; 2000; 8(3):162-8. PubMed ID: 10886806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.